Bioceres Crop Solutions (NASDAQ:BIOX – Get Free Report) issued its quarterly earnings data on Wednesday. The company reported ($0.16) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.02 by ($0.18), Zacks reports. The business had revenue of $53.80 million during the quarter. Bioceres Crop Solutions had a negative return on equity of 72.02% and a negative net margin of 105.94%.
Bioceres Crop Solutions Stock Performance
BIOX stock traded down $0.01 during midday trading on Friday, hitting $0.21. 85,497 shares of the company traded hands, compared to its average volume of 467,188. Bioceres Crop Solutions has a twelve month low of $0.19 and a twelve month high of $1.75. The company has a quick ratio of 0.62, a current ratio of 0.80 and a debt-to-equity ratio of 1.76. The business has a 50 day simple moving average of $0.31 and a 200-day simple moving average of $0.43. The stock has a market capitalization of $13.40 million, a price-to-earnings ratio of -0.06 and a beta of 0.54.
Wall Street Analyst Weigh In
Separately, Weiss Ratings restated a “sell (d-)” rating on shares of Bioceres Crop Solutions in a report on Friday, October 9th. One research analyst has rated the stock with a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Reduce” and a consensus price target of $2.00.
Bioceres Crop Solutions Company Profile
Bioceres Crop Solutions Corp. is an Argentina-based agricultural biotechnology company focused on developing technologies that improve crop productivity, resilience and sustainability. The company serves farmers and agricultural businesses through products designed to support crop establishment, nutrition, protection and performance under challenging environmental conditions. Its portfolio includes the HB4 biotechnology platform, which is used in drought-tolerant wheat and soybean varieties, as well as biological seed treatments, microbial inoculants, biofertilizers, biostimulants and biological crop-protection products.
Featured Articles
- Five stocks we like better than Bioceres Crop Solutions
- Nu Holdings Earnings Show a Compounder Priced Like a Brazil Bet
- Game On: The Hidden Value in Take-Two’s Stock
- LightPath Technologies’ Record Backlog Highlights a Bigger Defense Opportunity
- A 10-Stock Strategy That Balances AI Growth With Cash Flow
Receive News & Ratings for Bioceres Crop Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioceres Crop Solutions and related companies with MarketBeat.com's FREE daily email newsletter.
